Edition:
United States

PAVmed Inc (PAVM.OQ)

PAVM.OQ on NASDAQ Stock Exchange Capital Market

2.45USD
15 Dec 2017
Change (% chg)

$-0.29 (-10.58%)
Prev Close
$2.74
Open
$2.65
Day's High
$2.79
Day's Low
$2.45
Volume
6,018
Avg. Vol
4,521
52-wk High
$9.25
52-wk Low
$2.45

Select another date:

Tue, Nov 28 2017

BRIEF-Pavmed Files 510(K) Submission With Fda For Carpx Device To Treat Carpal Tunnel Syndrome

* PAVMED FILES 510(K) SUBMISSION WITH FDA FOR CARPX™ DEVICE TO TREAT CARPAL TUNNEL SYNDROME

BRIEF-Pavmed reports Q3 adjusted non-GAAP loss per share $0.13

* Q3 adjusted non-GAAP loss per share $0.13 Source text for Eikon: Further company coverage:

BRIEF-Pavmed offers up to 2.7 mln shares

* Pavmed files for offering of up to 2.7 million shares of co that may be offered for resale by selling stockholders - SEC filing Source text: http://bit.ly/2iDN6XW Further company coverage:

BRIEF-Pavmed says has received a letter from FDA regarding its portio intraosseous infusion system​

* Pavmed Inc - has received a letter from food and drug administration regarding its portio intraosseous infusion system​

BRIEF-PAVmed files for mixed shelf of up to $75 million

* PAVmed files for mixed shelf of up to $75 million - SEC filing Source text: (http://bit.ly/2hkAgwR) Further company coverage:

BRIEF-Pavmed CEO Lishan Aklog buys 9,100 shares of co's common stock

* Pavmed Inc CEO ‍lishan Aklog reports purchase of 9,100 shares of co's common stock between Aug 23-24 - SEC filing ​ Source text: (http://bit.ly/2vdLcGE) Further company coverage:

Select another date: